Skip to main content
Top
Published in: Endocrine Pathology 4/2013

01-12-2013

Predictive Factors of Malignancy in Thyroid Nodules with a Cytological Diagnosis of Follicular Neoplasm

Authors: Seong Hyeon Lee, Jeong Su Baek, Joo Young Lee, Jung Ah Lim, Soo Youn Cho, Tae Hyun Lee, Yun Hyi Ku, Hong Il Kim, Min Joo Kim

Published in: Endocrine Pathology | Issue 4/2013

Login to get access

Abstract

In cases of follicular neoplasm identified by thyroid fine-needle aspiration (FNA), surgery is required to achieve a precise diagnosis. We investigated potential clinical factors for the preoperative prediction of malignancy in thyroid nodules with a cytological diagnosis of follicular neoplasm. We retrospectively reviewed the data of 97 patients who were diagnosed with follicular neoplasm by FNA and had undergone surgery at the Korea Cancer Center Hospital between April 2010 and April 2012. Age, sex, laboratory data (such as thyroid-stimulating hormone, free T4, thyroglobulin (Tg), and Tg antibody), and ultrasonographic findings were reviewed from the electronic medical records. Of 97 patients, 50 (51.5 %) were diagnosed with benign nodules, 16 (16.5 %) with follicular thyroid carcinoma (FTC), and 31 (32.0 %) with papillary thyroid carcinoma (PTC). In comparison with the features of benign nodules, FTC presented with a large nodule size, high serum Tg level, isoechogenicity, calcifications, and peripheral halo, whereas PTC exhibited traits similar to those of benign nodules, except for high serum Tg level and the presence of calcifications on ultrasonography. Therefore, a high serum Tg level (≥75 ng/mL) and calcification were the only significant predictive factors for malignancy in case of follicular neoplasm (p < 0.01). Serum Tg levels and the presence of calcification on ultrasonography are important clinical features to predict malignancy in thyroid nodules with cytological diagnosis of follicular neoplasm.
Appendix
Available only for authorised users
Literature
1.
go back to reference Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295:2164–2167.PubMedCrossRef Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295:2164–2167.PubMedCrossRef
2.
go back to reference Liu S, Semenciw R, Ugnat AM, Mao Y (2001) Increasing thyroid cancer incidence in Canada, 1970–1996: time trends and age–period–cohort effects. Br J Cancer 85:1335–1339.PubMedCrossRef Liu S, Semenciw R, Ugnat AM, Mao Y (2001) Increasing thyroid cancer incidence in Canada, 1970–1996: time trends and age–period–cohort effects. Br J Cancer 85:1335–1339.PubMedCrossRef
4.
go back to reference Cibas ES, Ali SZ (2009) The Bethesda System for Reporting Thyroid Cytopathology. Thyroid 19:1159–1165.PubMedCrossRef Cibas ES, Ali SZ (2009) The Bethesda System for Reporting Thyroid Cytopathology. Thyroid 19:1159–1165.PubMedCrossRef
5.
go back to reference Baloch ZW, LiVolsi VA, Asa SL, Rosai J, Merino MJ, Randolph G, Vielh P, DeMay RM, Sidawy MK, Frable WJ (2008) Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 36:425–437.PubMedCrossRef Baloch ZW, LiVolsi VA, Asa SL, Rosai J, Merino MJ, Randolph G, Vielh P, DeMay RM, Sidawy MK, Frable WJ (2008) Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 36:425–437.PubMedCrossRef
6.
go back to reference Bongiovanni M, Spitale A, Faquin WC, Mazzucchelli L, Baloch ZW (2012) The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis. Acta Cytol 56:333–339.PubMedCrossRef Bongiovanni M, Spitale A, Faquin WC, Mazzucchelli L, Baloch ZW (2012) The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis. Acta Cytol 56:333–339.PubMedCrossRef
7.
go back to reference DeMay RM (2000) Follicular lesions of the thyroid. W(h)ither follicular carcinoma? Am J Clin Pathol 114:681–683PubMedCrossRef DeMay RM (2000) Follicular lesions of the thyroid. W(h)ither follicular carcinoma? Am J Clin Pathol 114:681–683PubMedCrossRef
8.
go back to reference LiVolsi VA, Baloch ZW (2011) Follicular-patterned tumors of the thyroid: the battle of benign vs. malignant vs. so-called uncertain. Endocr Pathol 22:184–189PubMedCrossRef LiVolsi VA, Baloch ZW (2011) Follicular-patterned tumors of the thyroid: the battle of benign vs. malignant vs. so-called uncertain. Endocr Pathol 22:184–189PubMedCrossRef
9.
go back to reference Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214.PubMedCrossRef Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214.PubMedCrossRef
10.
go back to reference Petric R, Perhavec A, Gazic B, Besic N (2012) Preoperative serum thyroglobulin concentration is an independent predictive factor of malignancy in follicular neoplasms of the thyroid gland. J Surg Oncol 105:351–356.PubMedCrossRef Petric R, Perhavec A, Gazic B, Besic N (2012) Preoperative serum thyroglobulin concentration is an independent predictive factor of malignancy in follicular neoplasms of the thyroid gland. J Surg Oncol 105:351–356.PubMedCrossRef
11.
go back to reference Tuttle RM, Lemar H, Burch HB (1998) Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid 8:377–383.PubMedCrossRef Tuttle RM, Lemar H, Burch HB (1998) Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid 8:377–383.PubMedCrossRef
12.
go back to reference Lubitz CC, Faquin WC, Yang J, Mekel M, Gaz RD, Parangi S, Randolph GW, Hodin RA, Stephen AE (2010) Clinical and cytological features predictive of malignancy in thyroid follicular neoplasms. Thyroid 20:25–31.PubMedCrossRef Lubitz CC, Faquin WC, Yang J, Mekel M, Gaz RD, Parangi S, Randolph GW, Hodin RA, Stephen AE (2010) Clinical and cytological features predictive of malignancy in thyroid follicular neoplasms. Thyroid 20:25–31.PubMedCrossRef
13.
go back to reference Castro MR, Espiritu RP, Bahn RS, Henry MR, Gharib H, Caraballo PJ, Morris JC (2011) Predictors of malignancy in patients with cytologically suspicious thyroid nodules. Thyroid 21:1191–1198.PubMedCrossRef Castro MR, Espiritu RP, Bahn RS, Henry MR, Gharib H, Caraballo PJ, Morris JC (2011) Predictors of malignancy in patients with cytologically suspicious thyroid nodules. Thyroid 21:1191–1198.PubMedCrossRef
14.
go back to reference Lee EK, Chung KW, Min HS, Kim TS, Kim TH, Ryu JS, Jung YS, Kim SK, Lee YJ (2012) Preoperative serum thyroglobulin as a useful predictive marker to differentiate follicular thyroid cancer from benign nodules in indeterminate nodules. J Korean Med Sci 27:1014–1018.PubMedCrossRef Lee EK, Chung KW, Min HS, Kim TS, Kim TH, Ryu JS, Jung YS, Kim SK, Lee YJ (2012) Preoperative serum thyroglobulin as a useful predictive marker to differentiate follicular thyroid cancer from benign nodules in indeterminate nodules. J Korean Med Sci 27:1014–1018.PubMedCrossRef
15.
go back to reference Kihara M, Hirokawa M, Ito Y, Kobayashi K, Miya A, Miyauchi A (2011) Final pathology findings after immediate or delayed surgery in patients with cytologically benign or follicular thyroid nodules. World J Surg 35:558–562.PubMedCrossRef Kihara M, Hirokawa M, Ito Y, Kobayashi K, Miya A, Miyauchi A (2011) Final pathology findings after immediate or delayed surgery in patients with cytologically benign or follicular thyroid nodules. World J Surg 35:558–562.PubMedCrossRef
16.
go back to reference Kihara M, Ito Y, Hirokawa M, Masuoka H, Yabuta T, Tomoda C, Higashiyama T, Inoue H, Fukushima M, Takamura Y, Kobayashi K, Miya A, Miyauchi A (2011) Role of ultrasonography in patients with cytologically follicular thyroid tumor. Auris Nasus Larynx 38:508–511.PubMedCrossRef Kihara M, Ito Y, Hirokawa M, Masuoka H, Yabuta T, Tomoda C, Higashiyama T, Inoue H, Fukushima M, Takamura Y, Kobayashi K, Miya A, Miyauchi A (2011) Role of ultrasonography in patients with cytologically follicular thyroid tumor. Auris Nasus Larynx 38:508–511.PubMedCrossRef
17.
go back to reference Kelman AS, Rathan A, Leibowitz J, Burstein DE, Haber RS (2001) Thyroid cytology and the risk of malignancy in thyroid nodules: importance of nuclear atypia in indeterminate specimens. Thyroid 11:271–277.PubMedCrossRef Kelman AS, Rathan A, Leibowitz J, Burstein DE, Haber RS (2001) Thyroid cytology and the risk of malignancy in thyroid nodules: importance of nuclear atypia in indeterminate specimens. Thyroid 11:271–277.PubMedCrossRef
18.
go back to reference Bartolazzi A, Orlandi F, Saggiorato E, Volante M, Arecco F, Rossetto R, Palestini N, Ghigo E, Papotti M, Bussolati G, Martegani MP, Pantellini F, Carpi A, Giovagnoli MR, Monti S, Toscano V, Sciacchitano S, Pennelli GM, Mian C, Pelizzo MR, Rugge M, Troncone G, Palombini L, Chiappetta G, Botti G, Vecchione A, Bellocco R (2008) Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study. Lancet Oncol 9:543–549.PubMedCrossRef Bartolazzi A, Orlandi F, Saggiorato E, Volante M, Arecco F, Rossetto R, Palestini N, Ghigo E, Papotti M, Bussolati G, Martegani MP, Pantellini F, Carpi A, Giovagnoli MR, Monti S, Toscano V, Sciacchitano S, Pennelli GM, Mian C, Pelizzo MR, Rugge M, Troncone G, Palombini L, Chiappetta G, Botti G, Vecchione A, Bellocco R (2008) Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study. Lancet Oncol 9:543–549.PubMedCrossRef
19.
go back to reference Franco C, Martinez V, Allamand JP, Medina F, Glasinovic A, Osorio M, Schachter D (2009) Molecular markers in thyroid fine-needle aspiration biopsy: a prospective study. Appl Immunohistochem Mol Morphol 17:211–215.PubMedCrossRef Franco C, Martinez V, Allamand JP, Medina F, Glasinovic A, Osorio M, Schachter D (2009) Molecular markers in thyroid fine-needle aspiration biopsy: a prospective study. Appl Immunohistochem Mol Morphol 17:211–215.PubMedCrossRef
20.
go back to reference Sanchez N, Selvaggi SM (2006) Utility of cell blocks in the diagnosis of thyroid aspirates. Diagn Cytopathol 34:89–92.PubMedCrossRef Sanchez N, Selvaggi SM (2006) Utility of cell blocks in the diagnosis of thyroid aspirates. Diagn Cytopathol 34:89–92.PubMedCrossRef
21.
go back to reference Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P (2010) Cancer incidence in five continents. Vol. IX IARC Scientific Publication No. 160. Lyon: IARC Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P (2010) Cancer incidence in five continents. Vol. IX IARC Scientific Publication No. 160. Lyon: IARC
22.
go back to reference Kim ES, Nam-Goong IS, Gong G, Hong SJ, Kim WB, Shong YK (2003) Postoperative findings and risk for malignancy in thyroid nodules with cytological diagnosis of the so-called "follicular neoplasm". Korean J Intern Med 18:94–97PubMed Kim ES, Nam-Goong IS, Gong G, Hong SJ, Kim WB, Shong YK (2003) Postoperative findings and risk for malignancy in thyroid nodules with cytological diagnosis of the so-called "follicular neoplasm". Korean J Intern Med 18:94–97PubMed
23.
go back to reference Yim JH, Kim EY, Kim WG, Kim TY, Gong G, Hong SJ, Kim WB, Shong YK (2010) Postoperative findings of the cytological diagnosis of follicular neoplasm or hürthle cell neoplasm and the risk of malignancy. Endocrinol Metab 25:316–320.CrossRef Yim JH, Kim EY, Kim WG, Kim TY, Gong G, Hong SJ, Kim WB, Shong YK (2010) Postoperative findings of the cytological diagnosis of follicular neoplasm or hürthle cell neoplasm and the risk of malignancy. Endocrinol Metab 25:316–320.CrossRef
24.
go back to reference Yang J, Schnadig V, Logrono R, Wasserman PG (2007) Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer 111:306–315.PubMedCrossRef Yang J, Schnadig V, Logrono R, Wasserman PG (2007) Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer 111:306–315.PubMedCrossRef
25.
go back to reference Nagataki S, Nystrom E (2002) Epidemiology and primary prevention of thyroid cancer. Thyroid 12:889–896.PubMedCrossRef Nagataki S, Nystrom E (2002) Epidemiology and primary prevention of thyroid cancer. Thyroid 12:889–896.PubMedCrossRef
26.
go back to reference Kurian EM, Dawlett M, Wang J, Gong Y, Guo M (2012) The triage efficacy of fine needle aspiration biopsy for follicular variant of papillary thyroid carcinoma using the Bethesda reporting guidelines. Diagn Cytopathol 40 Suppl 1:E69-73.PubMedCrossRef Kurian EM, Dawlett M, Wang J, Gong Y, Guo M (2012) The triage efficacy of fine needle aspiration biopsy for follicular variant of papillary thyroid carcinoma using the Bethesda reporting guidelines. Diagn Cytopathol 40 Suppl 1:E69-73.PubMedCrossRef
27.
go back to reference Gulcelik NE, Gulcelik MA, Kuru B (2008) Risk of malignancy in patients with follicular neoplasm: predictive value of clinical and ultrasonographic features. Arch Otolaryngol Head Neck Surg 134:1312–1315.PubMedCrossRef Gulcelik NE, Gulcelik MA, Kuru B (2008) Risk of malignancy in patients with follicular neoplasm: predictive value of clinical and ultrasonographic features. Arch Otolaryngol Head Neck Surg 134:1312–1315.PubMedCrossRef
28.
go back to reference Sahin M, Gursoy A, Tutuncu NB, Guvener DN (2006) Prevalence and prediction of malignancy in cytologically indeterminate thyroid nodules. Clin Endocrinol (Oxf) 65:514–518.CrossRef Sahin M, Gursoy A, Tutuncu NB, Guvener DN (2006) Prevalence and prediction of malignancy in cytologically indeterminate thyroid nodules. Clin Endocrinol (Oxf) 65:514–518.CrossRef
29.
go back to reference Roti E, degli Uberti EC, Bondanelli M, Braverman LE (2008) Thyroid papillary microcarcinoma: a descriptive and meta-analysis study. Eur J Endocrinol 159:659–673.PubMedCrossRef Roti E, degli Uberti EC, Bondanelli M, Braverman LE (2008) Thyroid papillary microcarcinoma: a descriptive and meta-analysis study. Eur J Endocrinol 159:659–673.PubMedCrossRef
30.
go back to reference Cochand-Priollet B, Dahan H, Laloi-Michelin M, Polivka M, Saada M, Herman P, Guillausseau PJ, Hamzi L, Pote N, Sarfati E, Wassef M, Combe H, Raulic-Raimond D, Chedin P, Medeau V, Casanova D, Kania R (2011) Immunocytochemistry with cytokeratin 19 and anti-human mesothelial cell antibody (HBME1) increases the diagnostic accuracy of thyroid fine-needle aspirations: preliminary report of 150 liquid-based fine-needle aspirations with histological control. Thyroid 21:1067–1073.PubMedCrossRef Cochand-Priollet B, Dahan H, Laloi-Michelin M, Polivka M, Saada M, Herman P, Guillausseau PJ, Hamzi L, Pote N, Sarfati E, Wassef M, Combe H, Raulic-Raimond D, Chedin P, Medeau V, Casanova D, Kania R (2011) Immunocytochemistry with cytokeratin 19 and anti-human mesothelial cell antibody (HBME1) increases the diagnostic accuracy of thyroid fine-needle aspirations: preliminary report of 150 liquid-based fine-needle aspirations with histological control. Thyroid 21:1067–1073.PubMedCrossRef
31.
go back to reference Fadda G, Rossi ED, Raffaelli M, Pontecorvi A, Sioletic S, Morassi F, Lombardi CP, Zannoni GF, Rindi G (2011) Follicular thyroid neoplasms can be classified as low- and high-risk according to HBME-1 and Galectin-3 expression on liquid-based fine-needle cytology. Eur J Endocrinol 165:447–453.PubMedCrossRef Fadda G, Rossi ED, Raffaelli M, Pontecorvi A, Sioletic S, Morassi F, Lombardi CP, Zannoni GF, Rindi G (2011) Follicular thyroid neoplasms can be classified as low- and high-risk according to HBME-1 and Galectin-3 expression on liquid-based fine-needle cytology. Eur J Endocrinol 165:447–453.PubMedCrossRef
32.
go back to reference Alexander EK, Kennedy GC, Baloch ZW, Cibas ES, Chudova D, Diggans J, Friedman L, Kloos RT, LiVolsi VA, Mandel SJ, Raab SS, Rosai J, Steward DL, Walsh PS, Wilde JI, Zeiger MA, Lanman RB, Haugen BR (2012) Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med 367:705–715.PubMedCrossRef Alexander EK, Kennedy GC, Baloch ZW, Cibas ES, Chudova D, Diggans J, Friedman L, Kloos RT, LiVolsi VA, Mandel SJ, Raab SS, Rosai J, Steward DL, Walsh PS, Wilde JI, Zeiger MA, Lanman RB, Haugen BR (2012) Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med 367:705–715.PubMedCrossRef
Metadata
Title
Predictive Factors of Malignancy in Thyroid Nodules with a Cytological Diagnosis of Follicular Neoplasm
Authors
Seong Hyeon Lee
Jeong Su Baek
Joo Young Lee
Jung Ah Lim
Soo Youn Cho
Tae Hyun Lee
Yun Hyi Ku
Hong Il Kim
Min Joo Kim
Publication date
01-12-2013
Publisher
Springer US
Published in
Endocrine Pathology / Issue 4/2013
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-013-9263-x

Other articles of this Issue 4/2013

Endocrine Pathology 4/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.